For research use only. Not for therapeutic Use.
FGIN 1-43(Cat No.:M097918)is a synthetic peptide inhibitor that targets the G protein-coupled receptor (GPCR) signaling pathway, specifically modulating the activity of the FGIN receptor. It has shown potential in various therapeutic areas, particularly within cancer and neurological disease research, by inhibiting cellular processes related to tumor progression and neurodegenerative conditions. FGIN 1-43 works by blocking receptor interactions, ultimately disrupting downstream signaling that contributes to disease mechanisms. It is of interest in drug discovery as a potential candidate for the development of targeted therapies in oncology and neurology.
CAS Number | 145040-29-5 |
Synonyms | 2-[5-chloro-2-(4-chlorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide |
Molecular Formula | C28H36Cl2N2O |
Purity | ≥95% |
IUPAC Name | 2-[5-chloro-2-(4-chlorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide |
InChI | InChI=1S/C28H36Cl2N2O/c1-3-5-7-9-17-32(18-10-8-6-4-2)27(33)20-25-24-19-23(30)15-16-26(24)31-28(25)21-11-13-22(29)14-12-21/h11-16,19,31H,3-10,17-18,20H2,1-2H3 |
InChIKey | XTZUPNNVXIMWAR-UHFFFAOYSA-N |
SMILES | CCCCCCN(CCCCCC)C(=O)CC1=C(NC2=C1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl |